The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, M.-S.
Right arrow Articles by Giudice, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, M.-S.
Right arrow Articles by Giudice, G. J.
The Journal of Immunology, 1999, 162: 4991-4997.
Copyright © 1999 by The American Association of Immunologists

Identification and Characterization of Epitopes Recognized by T Lymphocytes and Autoantibodies from Patients with Herpes Gestationis1

M.-S. Lin2,*, M. A. Gharia*, S. J. Swartz*, L. A. Diaz*,{ddagger} and G. J. Giudice*,{dagger}

Departments of * Dermatology and {dagger} Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226; and {ddagger} Veterans Affairs Medical Center, Milwaukee, WI 53295

Autoantibodies associated with herpes gestationis (HG), a pregnancy-associated autoimmune skin disease, target the hemidesmosomal protein BP180. It was shown that the major noncollagenous stretch of the BP180 ectodomain (NC16A) harbors epitopes recognized by HG sera. Furthermore, Abs reactive with the homologous domain of murine BP180 are known to trigger a cutaneous blistering disease in mice by passive transfer experiments. The present study was aimed at characterizing the T cell responses and specificities of autoantibodies from two HG patients. Using immunoblotting and T cell proliferation assays, we have identified a 14-amino-acid stretch of the BP180 ectodomain (MCW-1; aa 507–520) that is recognized by both T cells and autoantibodies produced by the HG patients. The neonate born to one of these HG patients showed no signs of skin disease and had no detectable T cell response to the BP180 Ag, but did have a low titer of circulating anti-BP180 autoantibodies, presumably of maternal origin. BP180-specific T cell lines and clones developed from an HG patient specifically reacted with the MCW-1 epitope. The proliferative responses of these clones were restricted to HLA-DR, but not -DQ or -DP. These Ag-specific T cells expressed {alpha}/ß TCRs and a CD4 memory T cell phenotype and secreted IFN-{gamma} and IL-2, but not IL-4 or IL-6, suggesting that they are Th1-type lymphocytes. Further characterization of these Ag-specific T cells and autoantibodies will aid in elucidating the autoimmune mechanism(s) leading to the development of HG.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Thoma-Uszynski, W. Uter, S. Schwietzke, G. Schuler, L. Borradori, and M. Hertl
Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230
J. Immunol., February 1, 2006; 176(3): 2015 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. M. Powell, Y. Sakuma-Oyama, N. Oyama, S. Albert, B. Bhogal, F. Kaneko, T. Nishikawa, and M. M. Black
Usefulness of BP180 NC16a Enzyme-Linked Immunosorbent Assay in the Serodiagnosis of Pemphigoid Gestationis and in Differentiating Between Pemphigoid Gestationis and Pruritic Urticarial Papules and Plaques of Pregnancy
Arch Dermatol, June 1, 2005; 141(6): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
C. Sitaru, J. Powell, G. Messer, E.-B. Brocker, F. Wojnarowska, and D. Zillikens
Immunoblotting and Enzyme-Linked Immunosorbent Assay for the Diagnosis of Pemphigoid Gestationis
Obstet. Gynecol., April 1, 2004; 103(4): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. B. Yancey and C. A. Egan
Pemphigoid: Clinical, Histologic, Immunopathologic, and Therapeutic Considerations
JAMA, July 19, 2000; 284(3): 350 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.